Personalized Medicine & Pharmacogenomics

Join us to learn about how scientific advances in pharmacogenomics may affect numerous areas of law, including patient privacy, regulatory, commercial, medical malpractice, advertising and intellectual property issues.

Francis S. Collins, M.D., Ph.D., is the Director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). He led the successful NIH effort to complete the Human Genome Project (HGP), a complex multidisciplinary scientific enterprise directed at identifying all human genes and sequencing the full complement of human DNA. His research has led to the identification of genes responsible for cystic fibrosis, neurofibromatosis, Huntington's disease and Hutchison-Gilford progeria syndrome. He is a member of the Institute of Medicine and the National Academy of Sciences.

Professor Toby Citrin, J.D., is the Director of the Michigan Center for Genomics and Public Health, and is an adjunct professor in the University of Michigan School of Public Health. Professor Citrin has pursued a career as attorney, business executive and public health activist after receiving his J.D. degree from Harvard in 1959. He has held numerous positions on state and local public health planning, policy, and advisory bodies, and chaired the Governor's Commission which developed Michigan's first Public Health Code.

This Roundtable Event will be held via Teleconference. There is no charge for participation in this event. Please note that the Roundtable may be accessed via the Toll Free Number listed below.

Click here to Register Today!